A
Allocade
Biotech & Life Sciences · Menlo Park, United States · Founded 2004
Allocade - Patient Flow, Transport & Communications for Hospitals MoreLess
Founded in 2007 by Michael Cline and Tom Spann, and headquartered in Plymouth Meeting, Pennsylvania, Allocade, Inc. operates as a key player in the personalized healthcare advocacy sector. The company's creation was reportedly inspired by co-founder Michael Cline's personal difficulties navigating the healthcare system, which highlighted a need for enhanced patient guidance. Allocade's primary business model is centered on a B2B approach, serving employers who then offer the company's healthcare solutions to their employees and families. As of early 2024, the company catered to over 1,200 commercial customers, reaching more than 14 million members.
Allocade's revenue is primarily generated through recurring per-member-per-month (PMPM) fees paid by employers and health plans. This subscription-based model is often supplemented by performance-based contracts, which are tied to documented healthcare cost reductions for their clients. The company's service offerings are diverse, encompassing personalized health guidance, expert medical opinion services, and virtual primary care. This is delivered through a combination of human interaction and technology; each member is paired with a Care Advocate who provides support, while an underlying technology platform utilizes AI and data analytics to offer personalized recommendations and streamline the healthcare experience. This integrated platform aims to address the complexities of the healthcare system, helping members understand benefits, find providers, and make informed care decisions.
The company has expanded its capabilities through strategic acquisitions. In 2021 and 2022, Allocade acquired PlushCare, 2nd.MD, and HealthReveal, which allowed it to integrate virtual primary care, mental health support, and expert medical opinion services into its platform. This evolution transformed the company from a navigation service to a more comprehensive healthcare provider. The company went public on the Nasdaq stock exchange under the ticker symbol ACCD in 2020. In early 2025, it was announced that Allocade was acquired by Transcarent.
Keywords: healthcare navigation, employee health benefits, personalized healthcare, virtual primary care, healthcare advocacy, care coordination, expert medical opinion, benefits navigation, digital health platform, health technology, employer healthcare solutions, member engagement, care management, virtual health, mental health support, healthcare cost reduction, patient advocacy, PMPM, health benefits management, population health management
Talent graph
Allocade's talent
Source: Dealroom Talent Intelligence.
Investors
1 investor on Allocade's cap table
Sourced from Dealroom's funding and investor records.

Global footprint
Where Allocade has talent and traffic
Market sentiment
What the market is saying about Allocade
An AI-synthesized read of the highest-engagement posts about Allocade on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Allocade on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.